About U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
During the past decade, U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials, followed by "Associazione Qol-one" with 2 trials
sponsored, "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "Nuovo Regina Margherita Hospital" with 1 trials sponsored and "Promefarm S.r.l."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
According to Clinical.Site data, the most researched conditions in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita" are
"Myelodysplastic Syndromes" (2 trials), "B-cell" (1 trials), "CLL" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colonic Polyp" (1 trials). Many other conditions were trialed in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita" in a lesser frequency.
Clinical Trials Intervention Types at U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
Most popular intervention types in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita" are "Drug" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Eltrombopag/Revolade" (2 trials), "Placebo" (2 trials), "2L PEG-ASC" (1 trials), "2L PEG-CS plus bisacodyl" (1 trials) and "Bortezomib-Rituximab-Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
The vast majority of trials in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita" are
9 trials for "All" genders.
Clinical Trials Status at U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita
Currently, there are NaN active trials in "U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".